UNSPSC 51101657: Etofamide

This classification denotes an antiprotozoal agent with the molecular formula C19H20Cl2N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03F36JH21U, chemically known as 2,2-dichloro-n-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide but generally known as etofamide, which bears US NIH Compound Identifier 65718. European Medicines Agency schedules Etofamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07318MIG.

UNSPSC 51101657 Etofamide, a Commodity code, shows little relevant recent activity aligned with the code's nominal scope. The two most recent state and local opportunities posted under this code do not involve etofamide procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over 12 months with two renewal options; this was an IFB process closed to award. Seminole County, Florida, solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through a competitive bid posted June 30, 2026, with a July 26, 2023 response deadline. Neither opportunity involves etofamide or related pharmaceutical compounds, suggesting the code may be mislabeled in the source data or sees minimal acquisition activity in state and local procurement pipelines.

State and local agencies issuing under this code span health departments and county health systems, but the geographic spread and issuing-body mix remain unclear given the mismatch between the code's scope and actual recent solicitations. Illinois and Florida appear in the recent record, but these represent pharmaceutical procurement broadly rather than demand specifically for etofamide. Business development professionals should verify whether etofamide aligns with their product or service portfolio before pursuing opportunities tagged to this code, and consider whether the mislabeling reflects a broader data-quality issue or a genuinely quiet procurement category.